🦊/Investors

View Ventures

Venture capital

Dallas · Pre-Seed–Series A · 1 people tracked

Also known as VV MANAGEMENT LLC

Find your way into View Ventures

Fox Verdict
Sign up to see your fit

Investment thesis

View Ventures invests in earlier-stage medical and health technology companies, applying a refined and tested investment philosophy. The firm typically takes board seats at its portfolio companies, reflecting a hands-on approach to supporting the development of life science and medical device businesses. Its focus areas draw on the founder's extensive background in life science investment funds and prior board roles at medical technology companies.

Source: firm website, verified Sep 15, 2026.

Stage
Pre-Seed–Series A
HQ
Dallas, US
Instruments
Equity
Founded
2020
Last 12 months
1 investment
Private fund assets
$27M
VC funds
1
Tracked investments
5

Team · 1 people

from the firm's website

What they invest in

from 5 of 5 portfolio companies

Healthtech ×5Medical Devices ×4Biotech ×1Hardware ×1

HQs:United States×4

Investments · 5 tracked

founders shown can be your intro path

By year:2025 · 12018 · 12 dated

Brius'brius.com

Brius (Brava) makes orthodontic teeth-straightening technology using its Independent Movers system, which it integrates with orthodontic practices.

HardwareHealthtechMedical Devices

Mehdi Peikar(Founder)in

Co-investorsCheyenne VenturesEvolution VC PartnersSand Hill AngelsTech Wildcatters

Euphrates Vasculareuphratesvascular.cominAug 2018

Euphrates Vascular develops the Pulse NanoMED System, a nanoscale interventional medical device that uses magnetically guided iron-oxide nanoparticles to reach and disrupt distal vascular occlusions beyond the reach of wires and catheters.

BiotechHealthtechMedical DevicesSt. Louis, US

Troy Long(Executive Officer)Jeffrey Blair(Director)Tim Blair(Executive Officer)inEric Moessinger(Director)Robert Mitchell(Director)Thomas Hillman(Director)

Co-investorsMissouri Technology CorporationOSF VenturesCultivation Capital

Rivermarkrivermarkmedical.comin

Rivermark Medical develops FloStent, a first-line device for treating benign prostatic hyperplasia (BPH) that is delivered during routine outpatient cystoscopy for urology practices and their patients.

HealthtechMedical DevicesMilwaukee, US

Anand Doraiswamy(Executive Officer, Director)Adam Kadlec(Co-founder)in

BoardScott Button(Director)Carter Meyer(Director)Matthew Ercolani(Director)Josh Baltzell(Director)

Co-investorsAndera Partners

Spirairspirair.comin

HealthtechSouth San Francisco, US

Ben Bishop(Executive Officer, Director)inJames Kintzing(Executive Officer, Director)

BoardRob Binney(Director)Carter Meyer(Director)Kate Garrett(Director)in

Co-investors1809 CapitalSonder Capital

Versa Vascularversavascular.cominDec 2025 · $27.3M

Versa Vascular is developing a tricuspid valve repair device with a delivery system designed for precise, repositionable implant placement.

HealthtechMedical DevicesSanta Cruz, US

Co-investorsSanta Cruz VentureBioStar CapitalCadence Healthcare VenturesS3 Ventures

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has View Ventures made?
View Ventures has 5 tracked investments, including 1 dated in the last 24 months.
What stage does View Ventures invest at?
View Ventures invests at the Pre-Seed, Seed, Series A stages.
What sectors does View Ventures focus on?
View Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is View Ventures located?
View Ventures is headquartered in Dallas, US.
Who does View Ventures co-invest with?
View Ventures most often shares deals with 1809 Capital, Cheyenne Ventures, Evolution VC Partners, among 10 tracked co-investors.

Images

View Ventures photo

Similar investors

Featured in lists